No Invasive Strategy Benefit at 5 Years in ISCHEMIA-CKD EXTEND ...Middle East

Medscape - News
The trial speaks to the lofty high-risk status of patients with CAD. 'You're seeing in a group of patients, with largely preserved EF but advanced CKD, a mortality rate close to 40% at 5 years.' Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( No Invasive Strategy Benefit at 5 Years in ISCHEMIA-CKD EXTEND )

Also on site :